| Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study T Fang, A Al Khleifat, JH Meurgey, A Jones, PN Leigh, G Bensimon, ... The Lancet Neurology 17 (5), 416-422, 2018 | 192 | 2018 |
| Comparison of the King’s and MiToS staging systems for ALS T Fang, A Al Khleifat, DR Stahl, C Lazo La Torre, C Murphy, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18 (3-4), 227-232, 2017 | 66 | 2017 |
| Systematic review of the efficacy of non-pharmacological interventions in people with Lewy body dementia H Morrin, T Fang, D Servant, D Aarsland, AP Rajkumar International Psychogeriatrics 30 (3), 395-407, 2018 | 47 | 2018 |
| Nonmotor symptoms in amyotrophic lateral sclerosis: a systematic review T Fang, F Jozsa, A Al-Chalabi International review of neurobiology 134, 1409-1441, 2017 | 40 | 2017 |
| Multi-input synapses, but not LTP-strengthened synapses, correlate with hippocampal memory storage in aged mice W Aziz, I Kraev, K Mizuno, A Kirby, T Fang, H Rupawala, K Kasbi, S Rothe, ... Current Biology 29 (21), 3600-3610. e4, 2019 | 31 | 2019 |
| A standard operating procedure for King’s ALS clinical staging R Balendra, A Al Khleifat, T Fang, A Al-Chalabi Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20 (3-4), 159-164, 2019 | 27 | 2019 |
| Telomere length is greater in ALS than in controls: a whole genome sequencing study A Al Khleifat, A Iacoangeli, A Shatunov, T Fang, W Sproviero, AR Jones, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20 (3-4), 229-234, 2019 | 19 | 2019 |
| Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents SA Johnson, T Fang, F De Marchi, D Neel, D Van Weehaeghe, JD Berry, ... Drugs 82 (13), 1367-1388, 2022 | 13 | 2022 |
| Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis F De Marchi, JD Berry, J Chan, S Caldwell, A Ellrodt, J Scalia, K Burke, ... Journal of Neurology 267, 1754-1759, 2020 | 11 | 2020 |
| Gene therapy in amyotrophic lateral sclerosis T Fang, G Je, P Pacut, K Keyhanian, J Gao, M Ghasemi Cells 11 (13), 2066, 2022 | 6 | 2022 |
| Age-dependent changes in autophosphorylation of alpha calcium/calmodulin dependent kinase II in hippocampus and amygdala after contextual fear conditioning T Fang, K Kasbi, S Rothe, W Aziz, KP Giese Brain Research Bulletin 134, 18-23, 2017 | 3 | 2017 |
| Characteristics and outcomes of postpartum cerebral venous sinus thrombosis: A subgroup analysis of the ACTION-CVT study T Fang, L Shu, M Elnazeir, AS Zubair, S Al Kasab, K Antonenko, ... Journal of stroke and cerebrovascular diseases 31 (12), 106865, 2022 | 1 | 2022 |
| Intuitive staging correlates with King’s clinical stage A Al Khleifat, R Balendra, T Fang, A Al-Chalabi Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22 (5-6), 336-340, 2021 | 1 | 2021 |
| Clinical and genetic characteristics associated with ALS diagnostic timeline: a population-based study (P10-8.005) T Fang, P Pacut, Y Sun, J Gao, B McNeilly, S Sivakumar, EIN Andrade, ... Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| Stage of prolonged survival in ALS–Author's reply A Al-Chalabi, T Fang, A Al Khleifat, JH Meurgey, A Jones, PN Leigh, ... The Lancet Neurology 17 (7), 579-580, 2018 | | 2018 |
ammar al-chalabiProfessor of Neurology and Complex Disease Genetics, King's College London在 kcl.ac.uk 的电子邮件经过验证
